IL113837A - ]) 3, 4 - Difluorophenoxy (methyl [oxirane and its preparation) - Google Patents

]) 3, 4 - Difluorophenoxy (methyl [oxirane and its preparation)

Info

Publication number
IL113837A
IL113837A IL11383792A IL11383792A IL113837A IL 113837 A IL113837 A IL 113837A IL 11383792 A IL11383792 A IL 11383792A IL 11383792 A IL11383792 A IL 11383792A IL 113837 A IL113837 A IL 113837A
Authority
IL
Israel
Prior art keywords
methyl
compound
difluorophenoxy
formula
filtered
Prior art date
Application number
IL11383792A
Other languages
English (en)
Hebrew (he)
Inventor
Raymond Antoine Stokbroekx
Gilbert Arthur Jules Grauwels
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL113837A publication Critical patent/IL113837A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Paper (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL11383792A 1991-02-25 1992-02-14 ]) 3, 4 - Difluorophenoxy (methyl [oxirane and its preparation) IL113837A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65964591A 1991-02-25 1991-02-25
IL10095292A IL100952A (en) 1991-02-25 1992-02-14 4 -]) 2-Benzothiazolyl (methylamino [-a-]) 3,4-difluorophenoxy-methyl [-1- piperidinethanol, its preparation and pharmaceutical preparations containing it

Publications (1)

Publication Number Publication Date
IL113837A true IL113837A (en) 1996-05-14

Family

ID=24646210

Family Applications (3)

Application Number Title Priority Date Filing Date
IL10095292A IL100952A (en) 1991-02-25 1992-02-14 4 -]) 2-Benzothiazolyl (methylamino [-a-]) 3,4-difluorophenoxy-methyl [-1- piperidinethanol, its preparation and pharmaceutical preparations containing it
IL11383792A IL113837A (en) 1991-02-25 1992-02-14 ]) 3, 4 - Difluorophenoxy (methyl [oxirane and its preparation)
IL11383795A IL113837A0 (en) 1991-02-25 1995-05-24 [(3,4-difluorophenoxy)methyl] oxirane and its preparation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL10095292A IL100952A (en) 1991-02-25 1992-02-14 4 -]) 2-Benzothiazolyl (methylamino [-a-]) 3,4-difluorophenoxy-methyl [-1- piperidinethanol, its preparation and pharmaceutical preparations containing it

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL11383795A IL113837A0 (en) 1991-02-25 1995-05-24 [(3,4-difluorophenoxy)methyl] oxirane and its preparation

Country Status (36)

Country Link
US (2) US5434168A (de)
EP (2) EP0573473B1 (de)
JP (1) JP2825652B2 (de)
KR (1) KR0165901B1 (de)
CN (3) CN1033454C (de)
AT (1) ATE131478T1 (de)
AU (1) AU649788B2 (de)
BG (1) BG62332B1 (de)
CA (1) CA2104000A1 (de)
CY (1) CY1924A (de)
CZ (1) CZ284705B6 (de)
DE (1) DE69206787T2 (de)
DK (1) DK0573473T3 (de)
DZ (1) DZ1560A1 (de)
EE (1) EE02983B1 (de)
ES (1) ES2083737T3 (de)
FI (1) FI933719A (de)
GR (1) GR3018692T3 (de)
HK (1) HK172296A (de)
HU (2) HUT67695A (de)
IE (1) IE69567B1 (de)
IL (3) IL100952A (de)
LV (1) LV11689B (de)
MA (1) MA22447A1 (de)
MX (1) MX9200777A (de)
NO (1) NO300591B1 (de)
NZ (2) NZ248437A (de)
PL (1) PL168791B1 (de)
RO (1) RO112959B1 (de)
RU (2) RU2094434C1 (de)
SK (1) SK278705B6 (de)
TN (1) TNSN92017A1 (de)
TW (1) TW218016B (de)
WO (1) WO1992014731A1 (de)
ZA (1) ZA921341B (de)
ZW (1) ZW1992A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
TW282469B (de) * 1993-06-11 1996-08-01 Janssen Pharmaceutica Nv
NZ295132A (en) * 1994-10-14 1998-06-26 Janssen Pharmaceutica Nv Sabeluzole aqueous suspension having ph from 8 to 10
EP0794777A1 (de) * 1994-11-24 1997-09-17 Janssen Pharmaceutica N.V. Lubeluzolhaltige intravenöse lösungen
JPH10501823A (ja) * 1995-04-10 1998-02-17 バクスター、インターナショナル、インコーポレイテッド クモ膜下出血の治療における架橋ヘモグロビンの使用
IL123083A0 (en) * 1995-10-25 1998-09-24 Janssen Pharmaceutica Nv Lubeluzole n-oxides their preparation and pharmaceutical compositions containing them
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
ATE296814T1 (de) * 1999-05-12 2005-06-15 Neurosearch As Ionenkanal modulierende mittel

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963732A (en) * 1973-05-30 1976-06-15 Tiberio Bruzzese Process for preparing dihydroxydiphenylmethane derivatives
US4310658A (en) * 1980-06-18 1982-01-12 Allied Corporation Production of polyester thermally stabilized with an oxirane
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
US4861785A (en) * 1984-12-03 1989-08-29 Janssen Pharmaceutica N.V. Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4717760A (en) * 1986-07-10 1988-01-05 The Dow Chemical Company Fluorinated tris-epoxides based on triphenyl methane
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
MA22447A1 (fr) 1992-10-01
LV11689A (lv) 1997-02-20
RU2094434C1 (ru) 1997-10-27
JP2825652B2 (ja) 1998-11-18
ZA921341B (en) 1993-08-24
US5434168A (en) 1995-07-18
EE02983B1 (et) 1997-04-15
RO112959B1 (ro) 1998-02-27
CN1033454C (zh) 1996-12-04
SK278705B6 (sk) 1998-01-14
PL168791B1 (pl) 1996-04-30
IL100952A0 (en) 1992-11-15
EP0501552A1 (de) 1992-09-02
HUT67695A (en) 1995-04-28
RU95112519A (ru) 1997-04-20
ATE131478T1 (de) 1995-12-15
IL100952A (en) 1995-12-31
HK172296A (en) 1996-09-20
BG98068A (bg) 1994-06-30
CN1043609C (zh) 1999-06-16
NZ241592A (en) 1994-07-26
BG62332B1 (bg) 1999-08-31
CA2104000A1 (en) 1992-08-26
HU211560A9 (en) 1995-12-28
DZ1560A1 (fr) 2002-02-17
IE69567B1 (en) 1996-10-02
AU1208592A (en) 1992-09-15
NO933010D0 (no) 1993-08-24
FI933719A0 (fi) 1993-08-24
DE69206787D1 (de) 1996-01-25
IE920575A1 (en) 1992-08-26
DE69206787T2 (de) 1996-06-05
EP0573473A1 (de) 1993-12-15
NO300591B1 (no) 1997-06-23
IL113837A0 (en) 1995-08-31
TW218016B (de) 1993-12-21
MX9200777A (es) 1992-08-01
ZW1992A1 (en) 1993-09-22
CN1064865A (zh) 1992-09-30
CN1113437A (zh) 1995-12-20
RU2106348C1 (ru) 1998-03-10
KR0165901B1 (en) 1999-01-15
EP0573473B1 (de) 1995-12-13
LV11689B (en) 1997-08-20
CS51292A3 (en) 1992-09-16
GR3018692T3 (en) 1996-04-30
JPH06505012A (ja) 1994-06-09
CY1924A (en) 1997-03-07
FI933719A (fi) 1993-08-24
CN1117048A (zh) 1996-02-21
US5675027A (en) 1997-10-07
WO1992014731A1 (en) 1992-09-03
NZ248437A (en) 1994-07-26
NO933010L (no) 1993-08-24
DK0573473T3 (da) 1996-01-29
CZ284705B6 (cs) 1999-02-17
HU9302395D0 (en) 1993-11-29
TNSN92017A1 (fr) 1993-06-08
AU649788B2 (en) 1994-06-02
ES2083737T3 (es) 1996-04-16

Similar Documents

Publication Publication Date Title
IL113837A (en) ]) 3, 4 - Difluorophenoxy (methyl [oxirane and its preparation)
EP0184257B1 (de) Benzoxazol- und Benzothiazolamin Derivate
JP5188501B2 (ja) モンテルカストおよびそのアミン塩類の精製方法
AU737334B2 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
CN1606548A (zh) 芳氧基苯基和芳硫基苯基衍生物
TWI380975B (zh) 製造胺基酚類化合物的方法
CN1275122A (zh) 制备噁唑烷酮的方法
JP2010524907A (ja) トリアゾロピリジンカルボキサミド誘導体、その調製およびその治療的使用
EP0912533B1 (de) Alkylaminobenzothiazole und -benzoxazole derivate
US8530474B2 (en) Substituted 6-(1-piperazinyl)-pyridazines as 5-HT6 receptor antagonists
CN1072661C (zh) 新的取代[2－(1－哌嗪基)乙氧基]甲基化合物
IE66198B1 (en) Antipsychotic 3-piperazinylbenzazole derivatives
CN101048392A (zh) 新用途
Adamo et al. An Improved Resolution Of 2-Methyl Piperidine And Its Use in The Synthesis Of Homochiral Trans-2, 6-Dialkyl Piperidines
US4861785A (en) Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
KR102491445B1 (ko) 광학분할에 의한 새로운 레보세티리진의 제조방법
US4749702A (en) Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US5010198A (en) Intermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agents
CN1044707C (zh) 取代的氨烷基氨基吡啶,及制备方法,应用和含有该化合物的药物组合物
JP7292517B2 (ja) オキセタン－２－イルメタンアミンの調製のためのプロセスおよび中間体
CA2525849A1 (en) 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
SK342590A3 (en) 2-imino-3-heterocyclylalkyl benzothiazoline derivatives, a method for producing same and pharmaceutical composition containing said compounds
US8765979B2 (en) Synthesis of (2S-cis)-2-(bromomethyl)-2-(4-chlorophenyl)-1,3 dioxolane-4-methanol methanesulfonate(ester)
CN116171269A (zh) D-丙氨酸烷基酯的制备方法
KR100230900B1 (ko) 피롤리딘 유도체 및 그의 제조 방법

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed